1887

Abstract

This study aimed to establish whether the bacterial density of spontaneous sputum is affected by the time and mode of sample storage. Ten patients with bronchiectasis collected all sputum expectorated over 45 min. The samples were aliquoted and processed at 25 °C for qualitative and quantitative bacteriology at 1, 2, 4 and 6 h from expectoration. Further aliquots were stored at 25 °C, 4 °C and −20 °C for 24 and 48 h prior to processing. The species present was identified and median (interquartile range) sputum log bacterial density (c.f.u. ml) calculated. All samples cultured grew and for two patients additionally grew for all samples. There was no significant difference in density in samples processed at 1, 2, 4 and 6 h following expectoration [8.2 (7.8–8.3) c.f.u. ml, 8.0 (7.8–8.3) c.f.u. ml, 8.0 (7.9–8.2) c.f.u. ml, 8.1 (7.9–8.2) c.f.u. ml, respectively, =0.392]. Storage for 24 and 48 h at 4 °C did not significantly change the bacterial load compared with processing at 1 h [8.03 (7.6–8.2) c.f.u. ml, =0.07, and 7.96 (7.49–8.22) c.f.u. ml, =0.09, respectively]. Storage for 24 and 48 h at −20 °C significantly reduced density [7.1 (6.1–7.7) c.f.u. ml, =0.005, and 6.9 (6.2–7.6) c.f.u. ml, =0.008, respectively]. Storage at 25 °C for 24 and 48 h was associated with a significant increase in bacterial load [8.3 (8.1–8.6) c.f.u. ml, =0.009, and 8.4 (8.1–8.5) c.f.u. ml, =0.03, respectively]. Bacterial density was not affected by storage for up to 6 h following expectoration at 25 °C; beyond this, storage at 4 °C is preferred.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.016683-0
2010-07-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/7/829.html?itemId=/content/journal/jmm/10.1099/jmm.0.016683-0&mimeType=html&fmt=ahah

References

  1. Angrill J., Agusti C., de Celis R., Rano A., Gonzalez J., Sole T., Xaubet A., Rodriguez-Roisin R., Torres A. 2002; Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 57:15–19 [CrossRef]
    [Google Scholar]
  2. Barker A. F., Couch L., Fiel S. B., Gotfried M. H., Ilowite J., Meyer K. C., O'Donnell A., Sahn S. A., Smith L. J. other authors 2000; Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 162:481–485 [CrossRef]
    [Google Scholar]
  3. Bilton D., Henig N., Morrissey B., Gotfried M. 2006; Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest 130:1503–1510 [CrossRef]
    [Google Scholar]
  4. Drobnic M. E., Sune P., Montoro J. B., Ferrer A., Orriols R. 2005; Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa . Ann Pharmacother 39:39–44
    [Google Scholar]
  5. Evans S. A., Turner S. M., Bosch B. J., Hardy C. C., Woodhead M. A. 1996; Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa . Eur Respir J 9:1601–1604 [CrossRef]
    [Google Scholar]
  6. Gleckman R., DeVita J., Hibert D., Pelletier C., Martin R. 1988; Sputum gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol 26:846–849
    [Google Scholar]
  7. Gould F. K., Freeman R., Hudson S., Magee J., Nelson D., Stafford R., Sisson P. R. 1996; Does storage of sputum specimens adversely affect culture results?. J Clin Pathol 49:684–686 [CrossRef]
    [Google Scholar]
  8. Hodson M. E., Gallagher C. G., Govan J. R. 2002; A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 20:658–664 [CrossRef]
    [Google Scholar]
  9. Jacobson J. T., Burke J. P., Jacobson J. A. 1981; Ordering patterns, collection, transport, and screening of sputum cultures in a community hospital: evaluation of methods to improve results. Infect Control 2:307–311
    [Google Scholar]
  10. Loebinger M. R., Wells A. U., Hansell D. M., Chinyanganya N., Devaraj A., Meister M., Wilson R. 2009; Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 34:843–849 [CrossRef]
    [Google Scholar]
  11. Martinez-Garcia M. A., Soler-Cataluna J. J., Perpina-Tordera M., Roman-Sanchez P., Soriano J. 2007; Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 132:1565–1572 [CrossRef]
    [Google Scholar]
  12. Murray M. P., Hill A. T. 2009; Non-cystic fibrosis bronchiectasis. Clin Med 9:164–169 [CrossRef]
    [Google Scholar]
  13. Naidich D. P., McCauley D. I., Khouri N. F., Stitik F. P., Siegelman S. S. 1982; Computed tomography of bronchiectasis. J Comput Assist Tomogr 6:437–444 [CrossRef]
    [Google Scholar]
  14. Pye A., Stockley R. A., Hill S. L. 1995; Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol 48:719–724 [CrossRef]
    [Google Scholar]
  15. Pye A., Hill S. L., Bharadwa P., Stockley R. A. 2008; Effect of storage and postage on recovery and quantitation of bacteria in sputum samples. J Clin Pathol 61:352–354
    [Google Scholar]
  16. Wilson C. B., Jones P. W., O'Leary C. J., Hansell D. M., Cole P. J., Wilson R. 1997; Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J 10:1754–1760 [CrossRef]
    [Google Scholar]
  17. Wong K., Roberts M. C., Owens L., Fife M., Smith A. L. 1984; Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol 17:113–119 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.016683-0
Loading
/content/journal/jmm/10.1099/jmm.0.016683-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error